Sutro Biopharma
STRO • NASDAQ
Sutro Biopharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jane Chung, with a market cap of $443.3M.
Market Cap$443.3M
Employees300.0
CEOJane Chung
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Sutro Biopharma FAQ
Common questions about Sutro Biopharma
Sutro Biopharma is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $8.4M.
Sutro Biopharma has approximately 300 employees.